Biomarin Pharmaceutical Inc $61.37

up +3.16


16/4/2014 08:10 PM  |  NASDAQ : BMRN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get BMRN Trend Analysis - it has underperformed the S&P 500 by 23%

Partner Headlines

  1. BioMarin, Medivation Buck Biotech Short Interest Trend (BIIB, BMRN, MDVN)

    Benzinga
  2. Amgen, BioMarin Lead Biotech Short Interest Trend (AMGN, BIIB, BMRN)

    Benzinga
  3. Top Trending Tickers On StockTwits For February 18

    Benzinga
  4. BioMarin Bucks Biotech Short Interest Trend (BIIB, BMRN, MDVN)

    Benzinga
  5. You Can No Longer Ignore Biotech

    GuruFocus
  6. New Year Short Interest Swings In Biotech (BIIB, BMRN, MDVN)

    Benzinga
  7. Celgene, Dendreon Lead Short Interest Trend In Biotechs (BMRN, CELG, DNDN)

    Benzinga
  8. UPDATE: Piper Jaffray Initiates Coverage on BioMarin Pharmaceutical on ...

    Benzinga
  9. UPDATE: Piper Jaffray Initiates On BioMarin Pharmaceuticals On BMN-111 ...

    Benzinga
  10. BioMarin Wins FDA Panel Vote, Cuts Deal With Myriad

    IBD
  11. Benzinga's Top #PreMarket Gainers

    Benzinga
  12. BioMarin Confirms FDA Panel Recommends Approval of Vimizim for Treatment ...

    Benzinga
  13. BioMarin Stock Trading Halted Today for FDA Endocrinologic and Metabolic ...

    Benzinga
  14. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    Benzinga
  15. Catalyst Stock Plunge: Ugly In Orphan Drug Land

    YCharts
  16. BioMarin Initiates Phase 3 BMN 673 Trial for Metastatic gBRCA Breast Cancer ...

    Benzinga
  17. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, ...

    Benzinga
  18. US Oncology, Biomarin Announce Collaboration to Launch PARP Inhibitor Phase ...

    Benzinga
  19. Roche

    IBD
  20. BioMarin Announces 5 Poster Presentations on BMN 673 at AACR-NCI-EORTC ...

    Benzinga
  21. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga
  22. Orphan Drugs: No (Payer) News Is Good News

    YCharts
  23. BioMarin Presents Positive Phase 1/2 Data on BMN 673 in Breast Cancer at ...

    Benzinga
  24. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)

    Benzinga
  25. Market Primer: Friday, September 20: US Markets Fall As Investors Re-Evaluate

    Benzinga
  26. Benzinga's M&A Chatter for Thursday September 19, 2013

    Benzinga
  27. Report: Roche Lines up $15B in Debt to Buy BioMarin

    FoxBusiness
  28. Benzinga's Volume Movers

    Benzinga
  29. Benzinga's Top Pre-Market Gainers

    Benzinga
  30. UPDATE: Stifel Downgrades BioMarin Pharmaceutical on Appropriate Risk/Reward, ...

    Benzinga
  31. Benzinga's Top Pre-Market Gainers

    Benzinga
  32. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, ...

    Benzinga
  33. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 2, ...

    GuruFocus
  34. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 14, ...

    GuruFocus
  35. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 5, ...

    GuruFocus
  36. UPDATE: Stifel Nicolaus Upgrades BioMarin Pharmaceutical on Catalysts

    Benzinga
  37. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 3, ...

    GuruFocus
  38. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 5, ...

    GuruFocus
  39. J.P. Morgan Reiterates Overweight Rating, $60 PT on BioMarin Pharmaceutical

    Benzinga
  40. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 17, ...

    GuruFocus
  41. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 9, ...

    GuruFocus
  42. BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques Bienaime sells 5, ...

    GuruFocus
  43. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 5, ...

    GuruFocus
  44. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 6, ...

    GuruFocus
  45. UPDATE: Wedbush Reiterates BioMarin Pharmaceuticals at Neutral with $46 ...

    Benzinga
  46. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 5, ...

    GuruFocus
  47. BioMarin, Prestige Brands and Other Top Performing Health Care Stocks in ...

    Benzinga
  48. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 8, ...

    GuruFocus
  49. Weekly Top Insider Sells? AAPL, GILD, BMRN, and PCLN

    GuruFocus
  50. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 4, ...

    GuruFocus
Trading Center